Pancreatic Cancer Research

ResearcherLanzhou University Second HospitalActive in the last 2 years

Shaozhen Rui

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5079628565. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044. Last author DOI 10.3389/fonc.2024.1521788↗
  2. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. Co-author DOI 10.1002/jcp.26816↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiao Li · 1 shared paper, 2024 · strength 0.28
  2. Wenkai Jiang · 1 shared paper, 2024 · strength 0.28
  3. Xiao‐Da Jin · 1 shared paper, 2018 · strength 0.08
  4. Hui Zhang · 1 shared paper, 2018 · strength 0.08
  5. Wenbo Meng · 1 shared paper, 2018 · strength 0.08
  6. Wence Zhou · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.